Skip to main content

Javier Hernandez Losa

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Javier Hernandez Losa

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Identificación de nuevas dianas para el tratamiento del cáncer basada en el estudio de factores cap-independientes activados en tumores malignos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Vicente Peg Camara, Trond Aasen
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 9283
Reference: FMM-2011-11
Duration: 01/09/2011 - 31/08/2012

Estudio de factores moleculares y vías de señalización asociados a resistencia/sensibilidad al tratamiento con Irvalec

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Javier Hernandez Losa
Funding agency: CENTRO PARA EL DESARROLLO TÉCNICO INDUSTRIAL (CDTI
Funding: 356298.75
Reference: CENIT-2009-01
Duration: 15/09/2009 - 31/12/2012

Papel de HER3 en la carcinogénesis de tumores de mama y endometrio. Búsqueda de nuevos factores predictivios de respuesta a tratamientos anti-HER

IP: Javier Hernandez Losa
Collaborators: Angel García Jiménez, Vicente Peg Camara
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 49200
Reference: FMM2009/02
Duration: 03/08/2009 - 02/08/2012

Papel de receptores epidermoides en cáncer. Papel de HER3 en tumores de mama y endometrio

IP: Javier Hernandez Losa
Collaborators: -
Funding agency: Fundación Caja Navarra
Funding: 6713.87
Reference: CAN2009-16662
Duration: 01/01/2010 - 31/12/2010

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Arnau Peñalver Piñol

Arnau Peñalver Piñol

Predoctoral researcher
Epidemiology and Public Health
Read more
Gerard Orriols Torras

Gerard Orriols Torras

Research technician
Pneumology
Read more
Joaquin Fernandez Doblas

Joaquin Fernandez Doblas

Predoctoral researcher
Donation and transplantation of organs, tissues and cells
Read more
Raisa Morales Martinez

Raisa Morales Martinez

Senior researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.